Psilocybin-Assisted Therapy Shows Promise for Veterans with Treatment-Resistant PTSD

The first U.S. clinical trial of psilocybin-assisted therapy in veterans with severe PTSD who failed conventional treatments demonstrated safety and efficacy, with no serious adverse events or increases in suicidal thinking. This groundbreaking research offers hope for treatment-resistant cases where standard medications and therapies have proven ineffective. The protocol combines psilocybin—a naturally occurring psychedelic compound—with professional therapeutic support to address deeply rooted trauma responses. For veterans struggling with debilitating PTSD symptoms, this potential therapeutic option could represent a transformative advancement in mental health care.

Originally published on
Medical Xpress
Read full article(opens in new tab)Fetched: July 30, 2026 at 10:02 AM



